Aberdeen Wealth Management LLC Abb Vie Inc. Transaction History

Aberdeen Wealth Management LLC

$146 Million
Q2 2024

A detailed history of Aberdeen Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Aberdeen Wealth Management LLC holds 14,992 shares of ABBV stock, worth $2.95 Million. This represents 1.76% of its overall portfolio holdings.

Number of Shares

14,992

Previous 14,939 0.35%

Holding current value

$2.95 Million

Previous $2.72 Million 5.48%

% of portfolio

1.76%

Previous 1.64%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$154.79 - $180.76 $8,203 - $9,580	53 Added 0.35%	14,992 $2.57 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $240,209 - $273,696	1,503 Added 11.19%	14,939 $2.72 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $212,867 - $239,738	-1,547 Reduced 10.33%	13,436 $2.08 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $400 - $463	3 Added 0.02%	14,983 $2.23 Million
Q2 2023 Aug 03, 2023	BUY	$132.51 - $164.9 $397 - $494	3 Added 0.02%	14,980 $2.02 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $14,027 - $16,154	-97 Reduced 0.64%	14,977 $2.39 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $270,672 - $324,607	-1,957 Reduced 11.49%	15,074 $2.44 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $402 - $461	3 Added 0.02%	17,031 $2.29 Million
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $412 - $524	3 Added 0.02%	17,028 $2.61 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $395 - $491	3 Added 0.02%	17,025 $2.76 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $322 - $407	3 Added 0.02%	17,022 $2.31 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $31,068 - $35,267	-292 Reduced 1.69%	17,019 $1.84 Million
Q2 2021 Jul 23, 2021	BUY	$105.21 - $117.21 $315 - $351	3 Added 0.02%	17,311 $1.95 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $42,966 - $47,300	-420 Reduced 2.37%	17,308 $1.87 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $33,805 - $45,641	420 Added 2.43%	17,728 $1.9 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $343 - $403	4 Added 0.02%	17,308 $1.52 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $4,108 - $5,498	56 Added 0.32%	17,304 $1.7 Million
Q1 2020 May 08, 2020	SELL	$64.5 - $97.79 $14,835 - $22,491	-230 Reduced 1.32%	17,248 $1.31 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $1.26 Million - $1.58 Million	17,478 New	17,478 $1.55 Million

Others Institutions Holding ABBV

# of Institutions

3,696

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $348B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aberdeen Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aberdeen Wealth Management LLC with notifications on news.

Account

Aberdeen Wealth Management LLC Abb Vie Inc. Transaction History